Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Christopher R. Chapple*, Victor W. Nitti, Vik Khullar, Jean Jacques Wyndaele, Sender Herschorn, Philip van Kerrebroeck, Mary Beth Blauwet, Emad Siddiqui

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1565-1572
JournalWorld Journal of Urology
Volume32
Issue number6
DOIs
Publication statusPublished - Dec 2014

Keywords

  • Mirabegron
  • Overactive bladder
  • beta(3)-Adrenoceptor agonist
  • Onset of action

Cite this